Home / CANCER BUZZ Podcast


Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple PodcastsSpotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Podcast Topics

Filter By Podcast Format

Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinking—solutions to help this population better access clinical trials, including a tool from the Leukemia and Lymphoma …
Hear how Vanderbilt University Medical Center created a model for integrating advanced practitioners into a radiation oncology satellite clinic to provide long-term follow-up care and survivorship services.
Stephen Quake, PhD, spoke to CANCER BUZZ about the application of liquid biopsies across multiple cancer stages and their potential to improve patient outcomes, minimize financial toxicity, and create health equity through greater testing access and lower cost.
Meeting the needs of cancer program staff to ultimately improve patient outcomes is at the heart of the presidential themes of ACCC’s current and immediate past presidents. CANCER BUZZ spoke to Krista Nelson, who advocated for the professional well-being of cancer program staff and Dr. David Penberthy, who aims to leverage technology to transform cancer care delivery and the patient experience. Hear …
While not yet mainstream in the community setting, hear how measurable residual disease (MRD) testing has the potential to become more fully integrated into clinical practice as one of the reliable markers of treatment response for patients with multiple myeloma and chronic lymphocytic leukemia.
Learn how state oncology societies have the power to mobilize larger groups of providers across the state to make their voices heard on behalf of their patients—and how you can get involved.
CANCER BUZZ spoke to Mike McGarry, who—following his wife’s cancer diagnosis—was introduced to Jack’s Caregiver Coalition, a non-profit dedicated to supporting men throughout the caregiver journey.
Hear how a virtual integrative format can enable cancer programs to adapt touch modalities to self-interventions, leverage opportunities for research, and overcome social and economic barriers.
Live from the ACCC 48th Annual Meeting & Cancer Center Business Summit, a veteran of value-based payment models identifies her top three takeaways on the future of precision medicine reimbursement.
Hear from the co-founder of the Imagination Lab for Clinical Innovation at LIVESTRONG Cancer Institutes on effective practices for measuring new models of care.
Dr. Jennie R. Crews, ACCC 2016-17 President, discusses ACCC's involvement in the White House's Cancer Moonshot initiative--from its launch in 2016 to the new energy generated by President Biden's revamp of the program in February 2022. Then hear how ACCC's legislative priorities into the Cancer Moonshot's commitment to increase cancer survivorship and reduce barriers to equitable cancer care.
Harlan Levine, MD, spoke to CANCER BUZZ during the ACCC 48th Annual Meeting & Cancer Center Business Summit to share his top takeaways from the stage.
Hear from a pharmacist and an oncology operations manager as they share how the digital Patient Assistance Guide tool can help you find resources in less time so patients can access—and better afford—their cancer treatments.
Precision medicine is increasingly critical to selecting the right treatment for patients with cancer, but pathology reporting can be lengthy, complex, and confusing—especially in this fast-paced molecular era. Hear one provider’s suggestions for simplifying and standardizing pathology reports so patients can be better informed, understand their prognosis, and own the progress of their therapies.
In this episode, hear from two experts in cancer immunotherapy on the exciting potential of TIL Cell Therapy in melanoma and beyond.
Hear from ACCC 2021-2022 President, Krista Nelson, MSW, LCSW, OSW-C, FAOSW, as she talks about two new resources (a business case brief for hiring and a benchmarking survey) coming from ACCC that demonstrate the value oncology social workers play in cancer care.
Biomarker testing is crucial to precision medicine, but barriers still exist. Learn from two healthcare advocates about recent policy changes designed to ensure better access to biomarker testing.
Hear from Colleen Campbell, PhD, MS, LGC, as she explains policy changes that can help patients access genetic counseling services, while also benefiting those who provide these services.
In this special podcast episode, we talk with oncology social worker and ACCC President Krista Nelson, MSW, LCSW, OSW-C, FAOSW, about finding opportunities to practice gratitude each day for colleagues and patients.
Hear from Wendi Waugh, Director of Cancer Services, Southern Ohio Medical Center, as she discusses the implementation of a process improvement plan with a focus on enhancing care for patients with advanced NSCLC.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.